Trials / Completed
CompletedNCT06337110
A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men
Interventional, Open-label, Single-dose Trial Investigating the Absorption, Metabolism, and Excretion (AME) of Lu AF28996 Following a Single Oral Dosing of 14C-Lu AF28996 to Healthy Men
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- Male
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The main goal of this study is to learn about how Lu AF28996 moves into, through, and out of the body after a single dose is given to healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lu AF28996 | Oral solution containing radiolabelled \[14C\]-Lu AF28996. |
Timeline
- Start date
- 2024-04-10
- Primary completion
- 2024-05-11
- Completion
- 2024-05-11
- First posted
- 2024-03-29
- Last updated
- 2024-10-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06337110. Inclusion in this directory is not an endorsement.